Project Details
| Short title | STML-ELA-0422 |
|---|---|
| Acronym | ELEGANT |
| Status | Active |
| Effective start/end date | 6/05/25 → 26/03/30 |
CTU: Elacestrant versus Standard Endocrine Therapy in Women and Men with Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer with High Risk of Recurrence—A Global, Multicenter, Randomized, Open-label Phase 3 Study (ELEGANT)
- Sabanathan, Dhanusha (Primary Chief Investigator)
- Quinlan, Gabriel (Clinical Trial Unit Staff)
- Martin, Lewis (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
- TAIDI, Gina (Clinical Trial Unit Staff)
- Armstrong, Emilia (Clinical Trial Unit Staff)
- Garcia, Michelle (Clinical Trial Unit Staff)
Project: Research